首页> 外文期刊>Journal of affective disorders >Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT
【24h】

Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT

机译:血清BDNF作为抗抑郁药和快速抗抑郁药的外围生物标志物:氯胺酮和ECT的比较

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Ketamine is associated with rapid antidepressant efficacy bat the biological mechanisms underpinning this effect are unclear. Serum brain-derived neurotrophic factor (sBDNF) is a potential circulating biomarker of treatment-resistant depression (TRD) and ketamine response but it is unclear if this is a common target of both ketamine and electroconvulsive therapy (ECU), the current gold standard for TRD. Moreover, the impact of multiple ketamine infusions on sBDNF has not yet been established.
机译:背景:氯胺酮与蝙蝠具有快速的抗抑郁功效,尚不清楚支持这种作用的生物学机制。血清脑源性神经营养因子(sBDNF)是抗药性抑郁症(TRD)和氯胺酮反应的潜在循环生物标志物,但目前尚不清楚这是否是氯胺酮和电惊厥疗法(ECU)的共同目标,目前是该疗法的金标准TRD。此外,尚未确定多次氯胺酮输注对sBDNF的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号